Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage: Clinical article

Journal of Neurosurgery

Volumn 119, Issue 1, 2013, Pages 198-206

  Tam, Alan K H ^a   Kapadia, Anish ^a   Ilodigwe, Don ^a   Li, Zeyu ^a   Schweizer, Tom A ^a,b   Macdonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cerebral atrophy; Cerebral infarction; Subarachnoid hemorrhage; Vascular disorders; Vasospasm

Indexed keywords

CLAZOSENTAN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN SIZE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENCEPHALOMALACIA; FEMALE; FUNCTIONAL STATUS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SUBARACHNOID HEMORRHAGE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGE DISTRIBUTION; AGED; ATROPHY; BRAIN; CEREBRAL INFARCTION; DIOXANES; DOUBLE-BLIND METHOD; EMBOLIZATION, THERAPEUTIC; ENCEPHALITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; POSTOPERATIVE COMPLICATIONS; PYRIDINES; PYRIMIDINES; RECEPTOR, ENDOTHELIN A; RECOVERY OF FUNCTION; RISK FACTORS; SEX DISTRIBUTION; SUBARACHNOID HEMORRHAGE; SULFONAMIDES; TETRAZOLES; TREATMENT OUTCOME;

EID: 84879945316     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.3.JNS121950     Document Type: Article

References (37)

1. Bell BA, Miller JD, Neto NG, O'Neill P, Laughton LM: Effect of naloxone on deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 16:498-501, 1985
2. Bendel P, Koivisto T, Aikiä M, Niskanen E, Könönen M, Hänninen T, et al: Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome. AJNR Am J Neuroradiol 31:370-376, 2010
3. Bendel P, Koivisto T, Hänninen T, Kolehmainen A, Könönen M, Hurskainen H, et al: Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology 67:575-582, 2006
4. Bendel P, Koivisto T, Niskanen E, Könönen M, Aikiä M, Hänninen T, et al: Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study. Neuroradiology 51:711-722, 2009
5. Biessels GJ, Koffeman A, Scheltens P: Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 253:477-482, 2006
6. Brott T, Adams HP Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-870, 1989
7. de Bresser J, Vincken KL, Kaspers AJ, Rinkel GJ, Viergever MA, Biessels GJ: Quantification of cerebral volumes on MRI 6 months after aneurysmal subarachnoid hemorrhage. Stroke 43:2782-2784, 2012
8. Dhar R, Diringer MN: The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 8:404-412, 2008
9. Dikmen S, Machamer J, Miller B, Doctor J, Temkin N: Functional status examination: a new instrument for assessing outcome in traumatic brain injury. J Neurotrauma 18:127-140, 2001
10. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al: Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123-135, 2003
11. Fergusen S, Macdonald RL: Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658-667, 2007
12. Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O'Brien JT, Ford GA: Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 254:713-721, 2007
13. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, et al: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 36:2121-2125, 2005
14. Hadjivassiliou M, Tooth CL, Romanowski CA, Byrne J, Battersby RD, Oxbury S, et al: Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology 56:1672-1677, 2001
15. Hale PM, McAllister JP II, Katz SD, Wright LC, Lovely TJ, Miller DW, et al: Improvement of cortical morphology in infantile hydrocephalic animals after ventriculoperitoneal shunt placement. Neurosurgery 31:1085-1096, 1992
16. Hudak AM, Caesar RR, Frol AB, Krueger K, Harper CR, Temkin NR, et al: Functional outcome scales in traumatic brain injury: a comparison of the Glasgow Outcome Scale (Extended) and the Functional Status Examination. J Neurotrauma 22:1319-1326, 2005
17. Kassell NF, Haley ECJ Jr., Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996
18. Lin X, Blumhardt LD: Inflammation and atrophy in multiple sclerosis: MRI associations with disease course. J Neurol Sci 189:99-104, 2001
19. Lindegaard KF, Sorteberg W, Nornes H: Transcranial Doppler in neurosurgery. Adv Tech Stand Neurosurg 20:39-80, 1993
20. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39: 3015-3021, 2008
21. Miklossy J: Chronic inflammation and amyloidogenesis in Alzheimer's disease - role of Spirochetes. J Alzheimers Dis 13:381-391, 2008
22. Ohman J, Servo A, Heiskanen O: Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74:14-20, 1991
23. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM: Underestimation of cognitive impairment by Mini- Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41:1290-1293, 2010
24. Risselada R, Lingsma HF, Bauer-Mehren A, Friedrich CM, Molyneux AJ, Kerr RS, et al: Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT). Eur J Epidemiol 25:261-266, 2010
25. Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, et al: Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 107:253-260, 2007
26. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL: Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315-2321, 2007
27. Salerno JA, Murphy DG, Horwitz B, DeCarli C, Haxby JV, Rapoport SI, et al: Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 20: 340-348, 1992
28. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC: A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60:989-994, 2003
29. Soininen H, Puranen M, Helkala EL, Laakso M, Riekkinen PJ: Diabetes mellitus and brain atrophy: a computed tomography study in an elderly population. Neurobiol Aging 13:717-721, 1992
30. Staff RT, Murray AD, Ahearn T, Salarirad S, Mowat D, Starr JM, et al: Brain volume and survival from age 78 to 85: the contribution of Alzheimer-type magnetic resonance imaging findings. J Am Geriatr Soc 58:688-695, 2010
31. Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, et al: Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocrit Care 13:182-189, 2010
32. Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922-935, 1992
33. van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W: Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend 82:111-118, 2006
34. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607, 1988
35. Wilson JT, Pettigrew LE, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15: 573-585, 1998
36. Yoshimoto Y, Tanaka Y, Hoya K: Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 32:1989-1993, 2001
37. Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, et al: Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 73:504-510, 2009